According to a report from Reuters, the President claimed that these drugs would cost $150 out-of-pocket. As of the time of ...

EMD Serono's agreement with the US government aims to expand IVF therapy access for 10 million women, offering significant ...

The Priority Review program is a new initiative launched by the current administration. It was first announced in June of ...

In today’s Pharmaceutical Executive Daily, we explore how antibody-drug conjugate collaborations are moving beyond oncology ...

Peptilogics Founder, CEO, Jonathan Steckbeck, explained that PLG0206 stands apart from current treatments, while the ...

As the pharmaceutical industry moves beyond rule-based omnichannel marketing, a new era of agentic systems is emerging, in which AI-powered agents collaborate with humans to orchestrate engagement, ...

What impact will TrumpRx and other DTC programs have on drug availability? Jesse Mendelsohn: To be clear, anything that expands access to pharmaceutical ...

PE: How do you see the relationship between financial leadership and innovation evolving within rare disease biotech companies? Smith: You know, finance leaders have to be comfort ...

Veradermics raised $150 million to advance VDPHL01, an oral minoxidil treatment for hair regrowth, through Phase III trials ...

In today’s Pharmaceutical Executive Daily, we explore how pharma leaders are rethinking workforce development at the ...

Boehringer Ingelheim and AimedBio collaborate on ADC therapy targeting a protein involved in cancer growth, aiming to enhance ...

Learn what makes an AI roleplay solution actually move the needle in pharma field team performance. Lead with insight with ...